Harvard professor-turned-Vertex fellow Doug Melton (Stephanie Mitchell/Harvard)
Doug Melton to reunite with his Semma collaborators at Vertex to develop 'curative cell therapies'
A reunion is happening at Vertex Pharmaceuticals as the biopharma pushes forward its work in type 1 diabetes with a leading biologist set to join …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
